These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 5257668)

  • 1. Autotransfusion of the freeze-dried ascites in patients with portal hypertension.
    Klen R; Recek C
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1969; ():Suppl:523-6. PubMed ID: 5257668
    [No Abstract]   [Full Text] [Related]  

  • 2. Dual origin of ascites in hepatic cirrhosis.
    Witte CL; Witte MH; Cole WR; Chung YC; Bleisch VR; Dumont AE
    Surg Gynecol Obstet; 1969 Nov; 129(5):1027-33. PubMed ID: 5824266
    [No Abstract]   [Full Text] [Related]  

  • 3. [Reinfusion of concentrated ascitic fluid. Hemostatic changes produced in the patients].
    Mate Jiménez J; Pajares García JM; García Gravalos R; Cantero Perona J
    Rev Clin Esp; 1979 Feb; 152(4):295-8. PubMed ID: 451306
    [No Abstract]   [Full Text] [Related]  

  • 4. [Splenectomy in patients with liver cirrhosis complicated by portal hypertension].
    Patsiora MD; Kniazeva GD; Ershov IuA; Morozov VA; Chumachenko PV
    Khirurgiia (Mosk); 1983 Jul; (7):60-3. PubMed ID: 6620913
    [No Abstract]   [Full Text] [Related]  

  • 5. Ascites in the state of Qatar: aetiology and diagnostic value of ascitic fluid analysis.
    Khan FY
    Singapore Med J; 2007 May; 48(5):434-9. PubMed ID: 17453102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of serum-ascites albumin gradient for the determination of portal hypertension in the diagnosis of ascites.
    Dittrich S; Yordi LM; de Mattos AA
    Hepatogastroenterology; 2001; 48(37):166-8. PubMed ID: 11268957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experience in the treatment of diuretic-resistant ascites in liver cirrhosis by intravenous infusion of autogenous ascitic fluid].
    Matsuoka K; Ueda Y; Kimura M; Mashiba Y; Kitsuki K
    Naika; 1971; 28(1):163-7. PubMed ID: 5565686
    [No Abstract]   [Full Text] [Related]  

  • 8. [Preoperative correction of the protein disturbances in portal hypertension].
    Patsiora MD; Cheberiak VG; Avramov VIu
    Klin Khir (1962); 1981 Sep; (9):22-5. PubMed ID: 7300141
    [No Abstract]   [Full Text] [Related]  

  • 9. Early enteral and parenteral nutritional support in patients with cirrhotic portal hypertension after pericardial devascularization.
    Zhang K; Sun WB; Wang HF; Li ZW; Zhang XD; Wang HB; Ji X
    Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):55-9. PubMed ID: 15730920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reinfusion of ascitic fluid in the treatment of ascites in patients with liver cirrhosis].
    Zhuravlev VA; Sukhorukov VP; Shishkin BA
    Sov Med; 1983; (2):95-7. PubMed ID: 6857357
    [No Abstract]   [Full Text] [Related]  

  • 11. HBsAg in ascitic fluid of patients with hepatic cirrhosis.
    Chlumsky J; Krtek V
    Hepatogastroenterology; 1982 Jun; 29(3):106-7. PubMed ID: 7106693
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathophysiology and management of portal hypertension. 2: Cirrhotic ascites.
    Stanley AJ; Bouchier IA; Hayes PC
    Br J Hosp Med; 1997 Jul 9-Aug 19; 58(2-3):74-8. PubMed ID: 9349370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of the detection of five kinds of protein in the blood and ascites of patients with cirrhosis].
    Lin YY
    Zhonghua Yi Xue Za Zhi; 1985 Sep; 65(9):539-41. PubMed ID: 3935289
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of mechanical factors on ascites formation in hepatic cirrhosis.
    Witte MH; Witte CL
    Lymphology; 1969 Sep; 2(3):89-91. PubMed ID: 5357967
    [No Abstract]   [Full Text] [Related]  

  • 15. The utility of evaluating low serum albumin gradient ascites in patients with cirrhosis.
    Khandwalla HE; Fasakin Y; El-Serag HB
    Am J Gastroenterol; 2009 Jun; 104(6):1401-5. PubMed ID: 19491852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Possibilities of surgical treatment of portal hypertension].
    Taubert E
    Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):99-106. PubMed ID: 5313236
    [No Abstract]   [Full Text] [Related]  

  • 17. Nationwide increase in hospitalizations and hepatitis C among inpatients with cirrhosis and sequelae of portal hypertension.
    Nguyen GC; Segev DL; Thuluvath PJ
    Clin Gastroenterol Hepatol; 2007 Sep; 5(9):1092-9. PubMed ID: 17625983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chylous ascites in cirrhotic and non-cirrhotic patients].
    Casafont F; López-Arias MJ; Crespo J; Dueñas C; Sánchez-Antolín G; Rivero M; Pons Romero F
    Gastroenterol Hepatol; 1997; 20(6):291-4. PubMed ID: 9296843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Personal experience with the reinfusion of concentrated ascitic fluid in liver cirrhosis].
    Cervinka J; Kordac V; Benes R
    Cas Lek Cesk; 1983 Mar; 122(10):302-5. PubMed ID: 6839336
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hydrothorax in absence of ascites: an unusual complication of hepatic cirrhosis with portal hypertension].
    Rombolà F; Spinoso A; Ranieri FS; Bertuccio A; Del Giudice AC; Bertuccio SN
    Clin Ter; 2005; 156(4):179-81. PubMed ID: 16342519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.